Billionaire Profile
Hu Kaijun
Global Rank
#824

Image: Public domain | via Wikimedia Commons

Hu Kaijun

CEO, Grand Pharmaceutical
CN
Real-Time Net Worth
$4.75B
As of December 2025
Age
63
Source
Pharmaceuticals
Industry
healthcare
Citizenship
CN

Biography

Hu Kaijun is a prominent figure in the pharmaceutical industry and the healthcare sector, currently holding the position of chairman and CEO of China Grand Enterprises. His estimated net worth is $4.75 billion as of November 5, 2025. Hu Kaijun's wealth stems primarily from his stakes in Huadong Medicine and Grand Pharmaceutical. His career highlights include leading China Grand Enterprises, an investment company with diverse interests in healthcare, real estate, agriculture, and financial services.

Wealth Over Time

In-Depth Profile

Early Life

Born and raised in China, Hu Kaijun developed an early interest in how businesses operate and industries evolve. He pursued higher education, focusing on business management and economics, which provided a foundation for analyzing markets and implementing effective strategies.

Rise to Success

After completing his education, Hu Kaijun began his professional journey, gaining experience and honing his skills in various companies. In the mid-1990s, he founded his own company, marking the start of his entrepreneurial journey. Under his leadership, the company expanded, with Hu Kaijun strategically investing in innovative technologies.

Key Business Strategies

Hu Kaijun's leadership emphasizes collaboration, innovation, and sustainability. He has diversified business interests into sectors such as real estate, finance, and renewable energy, demonstrating an ability to identify opportunities in emerging markets and invest strategically. His company's ability to attract top talent and maintain a competitive edge is a key aspect of his leadership.

Philanthropy

Hu Kaijun is known for his philanthropic efforts, supporting initiatives in education, healthcare, and environmental sustainability.

Career Milestones

1990s

Founded his own company

Began his entrepreneurial journey and laid the foundation for his career.

2000

Huadong Medicine went Public

Huadong Medicine went public on the Shenzhen Stock Exchange.

2018

Acquired BlackSwan Vascular

Grand Pharmaceutical, with Hu Kaijun as the biggest shareholder, acquired BlackSwan Vascular.

2023

Buy of BlackSwan Vascular

Grand Pharmaceutical agreed to buy 87.5% of U.S.-based vascular drug maker BlackSwan Vascular, Inc. for $37.5 million.

Philanthropy & Social Impact

Education

Education Initiatives

$XB

Hu Kaijun has funded scholarships and built schools.

Business Philosophy & Leadership

Notable Quotes

"Not Available"

Leadership Principles

Collaboration

Hu Kaijun emphasizes collaboration in his leadership style.

Innovation

Hu Kaijun promotes innovation within his company.

Sustainability

Hu Kaijun focuses on sustainability in his business practices.

Controversies & Challenges

Not Available

Not Available

Not Available